Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.

Agah E, Zardoui A, Saghazadeh A, Ahmadi M, Tafakhori A, Rezaei N.

PLoS One. 2018 Jan 18;13(1):e0190252. doi: 10.1371/journal.pone.0190252. eCollection 2018. Review.

2.

IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.

Zhao Q, Cheng W, Xi Y, Cao Z, Xu Y, Wu T, Li C, Niu X, Chen G.

Mol Immunol. 2018 Jan;93:20-30. doi: 10.1016/j.molimm.2017.11.002. Epub 2017 Nov 8.

PMID:
29127843
3.

Yes, research matters.

Shinohara ML.

PLoS Pathog. 2017 Aug 10;13(8):e1006420. doi: 10.1371/journal.ppat.1006420. eCollection 2017 Aug.

4.

Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.

Tortorella C, Direnzo V, Ruggieri M, Zoccolella S, Mastrapasqua M, D'Onghia M, Paolicelli D, Cuonzo FD, Gasperini C, Trojano M.

Mult Scler. 2018 Jul;24(8):1039-1045. doi: 10.1177/1352458517711774. Epub 2017 May 24.

PMID:
28537100
5.

Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Clemente N, Comi C, Raineri D, Cappellano G, Vecchio D, Orilieri E, Gigliotti CL, Boggio E, Dianzani C, Sorosina M, Martinelli-Boneschi F, Caldano M, Bertolotto A, Ambrogio L, Sblattero D, Cena T, Leone M, Dianzani U, Chiocchetti A.

Front Immunol. 2017 Mar 23;8:321. doi: 10.3389/fimmu.2017.00321. eCollection 2017.

6.

Osteopontin-metallothionein I/II interactions in experimental autoimmune encephalomyelitis.

Jakovac H, Grubić Kezele T, Šućurović S, Mulac-Jeričević B, Radošević-Stašić B.

Neuroscience. 2017 May 14;350:133-145. doi: 10.1016/j.neuroscience.2017.03.020. Epub 2017 Mar 24. Erratum in: Neuroscience. 2017 Sep 17;359:325.

7.

Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.

Vinther-Jensen T, Börnsen L, Budtz-Jørgensen E, Ammitzbøll C, Larsen IU, Hjermind LE, Sellebjerg F, Nielsen JE.

Neurol Neuroimmunol Neuroinflamm. 2016 Sep 28;3(6):e287. eCollection 2016 Dec.

8.

Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.

Strehlow F, Bauer S, Martus P, Weller M, Roth P, Schlegel U, Seidel S, Scheibenbogen C, Korfel A, Kreher S.

J Neurooncol. 2016 Aug;129(1):165-71. doi: 10.1007/s11060-016-2162-5. Epub 2016 Jun 13.

9.

Polymorphism of the osteopontin gene and clinical course of multiple sclerosis in the Polish population.

Biernacka-Lukanty J, Michalowska-Wender G, Michalak S, Raczak B, Kozubski W, Urbanski D, Wender M.

Folia Neuropathol. 2015;53(4):343-6.

10.

Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica.

Kariya Y, Kariya Y, Saito T, Nishiyama S, Honda T, Tanaka K, Yoshida M, Fujihara K, Hashimoto Y.

BBA Clin. 2015 Jan 15;3:126-34. doi: 10.1016/j.bbacli.2015.01.003. eCollection 2015 Jun.

11.

Osteopontin in Immune-mediated Diseases.

Rittling SR, Singh R.

J Dent Res. 2015 Dec;94(12):1638-45. doi: 10.1177/0022034515605270. Epub 2015 Sep 4. Review.

12.

Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.

Stilund M, Gjelstrup MC, Petersen T, Møller HJ, Rasmussen PV, Christensen T.

PLoS One. 2015 Apr 10;10(4):e0119681. doi: 10.1371/journal.pone.0119681. eCollection 2015.

13.

BAFF maintains T-cell survival by inducing OPN expression in B cells.

Ma N, He Y, Xiao H, Han G, Chen G, Wang Y, Wang K, Hou C, Yang X, Marrero B, Wang Y, Shen B, Li Y, Wang R.

Mol Immunol. 2014 Feb;57(2):129-37. doi: 10.1016/j.molimm.2013.08.014. Epub 2013 Sep 28.

PMID:
24084099
14.

Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.

Kivisäkk P, Healy BC, Francois K, Gandhi R, Gholipour T, Egorova S, Sevdalinova V, Quintana F, Chitnis T, Weiner HL, Khoury SJ.

Mult Scler. 2014 Apr;20(4):438-44. doi: 10.1177/1352458513503052. Epub 2013 Sep 4.

PMID:
24005026
15.

Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.

Shimizu Y, Ota K, Ikeguchi R, Kubo S, Kabasawa C, Uchiyama S.

J Neuroimmunol. 2013 Oct 15;263(1-2):148-51. doi: 10.1016/j.jneuroim.2013.07.005. Epub 2013 Jul 30.

PMID:
23910387
16.

Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.

Khademi M, Dring AM, Gilthorpe JD, Wuolikainen A, Al Nimer F, Harris RA, Andersson M, Brundin L, Piehl F, Olsson T, Svenningsson A.

PLoS One. 2013 May 7;8(5):e63172. doi: 10.1371/journal.pone.0063172. Print 2013.

17.

Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis.

Begum-Haque S, Christy M, Wang Y, Kasper E, Ochoa-Reparaz J, Smith JY, Haque A, Kasper LH.

J Neuroimmunol. 2013 Jan 15;254(1-2):117-24. doi: 10.1016/j.jneuroim.2012.10.003. Epub 2012 Nov 7.

PMID:
23141166
18.

Optic neuritis: experience from a south Indian demyelinating disease registry.

Pandit L, Shetty R, Misri Z, Bhat S, Amin H, Pai V, Rao R.

Neurol India. 2012 Sep-Oct;60(5):470-5. doi: 10.4103/0028-3886.103186.

19.

The impact of osteopontin gene variations on multiple sclerosis development and progression.

Comi C, Cappellano G, Chiocchetti A, Orilieri E, Buttini S, Ghezzi L, Galimberti D, Guerini F, Barizzone N, Perla F, Leone M, D'Alfonso S, Caputo D, Scarpini E, Cantello R, Dianzani U.

Clin Dev Immunol. 2012;2012:212893. Epub 2012 Sep 11.

20.

Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.

Wen SR, Liu GJ, Feng RN, Gong FC, Zhong H, Duan SR, Bi S.

J Neuroimmunol. 2012 Mar;244(1-2):94-6. doi: 10.1016/j.jneuroim.2011.12.004. Epub 2012 Feb 12.

PMID:
22329905

Supplemental Content

Loading ...
Support Center